Abstract:CRISPR-mediated selective DNA cleavage has revolutionized gene editing, but analogous methods to manipulate RNA, thus preserving the genome and avoiding potential adverse side effects, are not available. In their paper, Nemudraia et al. present an approach for the sequence-specific deletion of transcripts in human cells that makes use of type III-A CRISPR complexes, which cleave RNA in six-nucleotide increments. Type III-A CRISPR complexes have been previously used to knockdown RNA, but as shown here, the resulting CRISPR-guided RNA breaks are repaired by RtcB ligase in human cells, allowing for programmable RNA editing, for instance to restore gene function. As a proof-of-principle, the authors use this technology to remove premature stop codons in a reporter plasmid to restore protein expression in vitro, as well as excise clinically relevant nonsense mutations in the CFTR transcript in human bronchial epithelial cells carrying a disease allele. Furthermore, as type III CRISPR systems only require complementarity between the RNA guide and the RNA target, this method is highly adaptable and not restricted to the presence of any adjacent sequence motifs. Together, this work presents a versatile means to precisely edit RNA with potential therapeutic applications. Original reference: Science 384 , 808–814 (2024)

RNA editing with CRISPR